|
|
Side Effects of Rimonabant (Acomplia)
 Rimonabant Acomplia aimed at helping patients lose weight and quit smoking.
Rimonabant Acomplia is the first of a new class of drugs targeting the
endocannabiniod system, which helps to regulate pleasure, relaxation,
and pain tolerance.
Side effects of Acomplia Rimonabant were described as minor and temporary, the most frequent
being diarrhea, nausea, vomiting and dizziness. More severe anticipated
side effects, especially depression, did not materialize. it caused nausea in 13% of patients, vs. in 4% of those who got
placebo.
Anxiety and diarrhea also occurred at a higher rate in
patients taking rimonabant than in placebo casdepression and anxiety scores as measured by the Hospital Anxiety and Depression (HAD) scale.
Rimonabant Acomplia was found to increase blood pressure even as it facilitated weight loss. Some 40 per cent of Sanofi's test subjects dropped out during the first year of the obesity trials. "Some complained of nausea, diarrhea, vomiting, dizziness and headaches, as well as mood disorders including anxiety and depression," according to the New Scientist.
Acomplia Rimonabant Video
|
